References
- Phencyclidine Abuse Manual, M. A. McAdams, R. L. Linder, R. L. Lerner, R. S. Burns. University of California, Los Angeles 1980
- Golden N. L., Kuhnert B. R., Sokol R. J. Phencyclidine use during pregnancy. Am. J. Obstet. Gynecol. 1984; 148: 254–259
- Kaufman K., Petrucha R., Pins F., Kaufman E. Phencyclidine in umbilical cord blood: Preliminary data. Am. J. Psychiatry 1983; 140: 450–452
- MacGregor S. N., Keith L. G., Chasnoff I. J. Cocaine use during pregnancy: Adverse perinatal outcome. Am. J. Obstet. Gynecol. 1987; 157: 686–690
- Cherukuri R., Minkoff H., Feldman J. etal., Cohort study of alkaloidal cocaine (“crack”) in pregnancy. Obstet. Gynecol. 1988; 72: 147–151
- Golden N. L., Sokol R. J., Rubin I. L. Angel dust: Possible effects on the fetus. Pediatrics 1980; 65: 18–20
- Straus A. A., Modanlou H. D., Bosu S. K. Neonatal manifestations of maternal phencyclidine (PCP) abuse. Pediatrics 1981; 68: 550–552
- Chasnoff I. J., Burns W. J., Hatcher R. P., Burns K. A. Phencyclidine: Effects on the fetus and neonate. Dev. Pharmacol. Iher. 1983; 6: 404–408
- Howard J., Kropenske V., Tyler R. The long-term effects on neurodevelopment in infants exposed prenatally to PCP. Phencyclidine: An Update, D. H. Clouet. National Institute on Drug Abuse Research Monograph Series 64. 1985
- Kessner D. M., Singer J., Kalk C. E. Infant Death: An Analysis by Maternal Risk and Health Care. Institute of Medicine National Academy Press, Washington, D.C. 1973
- Williams R. L., Creasy R. K., Cunningham G. C. Fetal growth and perinatal viability in California. Obstet. Gynecol. 1982; 59: 624–632
- Harper R. G., Solish G. I., Purow H. M. The effect of a methadone treatment program upon pregnant heroin addicts and their newborn infants. Pediatrics 1974; 54: 300–305
- Rubin R. T., Wheeler N. C, Pregibon D., Poland R. E. Neuroendocrine aspects of primary endogenous depression VII. Logisitic regression analysis of matched patient-control hormone data for discrimination between groups. J. Psychiatr. Res. 1988; 22: 297–307
- Leonard B. E. Hallucinogenic drugs and central transmitter substances. Int. J. Neurosci. 1972; 4: 35–43
- Ilett K. F., Jarrott B., O'Donell S. R. Mechanism of cardiovascular actions of l-(-l-phenylcyclohexy) piperidine hydrochloride (phencyclidine). Br. J. Pharmacol. Chemother. 1966; 28: 73–83
- Hitner H. D., Gregorio G. J. Preliminary investigation of effects of phencyclidine. Arch. Int. Pharmacodyn. 1974; 212: 36–42
- Woods J. R., Plessinger M. A., Clark K. E. Effect of cocaine on uterine blood flow and fetal oxygenation. J. Am. Med. Assoc. 1987; 257: 957–961
- Golden N. L., Kuhnert B. R., Sokol R. J. Neonatal manifestations of maternal phencyclidine exposure. J. Perinat. Med. 1987; 15: 185–191
- Greenland S., Staisch K. J., Brown N., Gross S. The effects of marijuana use during pregnancy. I. A preliminary epidemiologic study. Am. J. Obstet. Oynecol. 1982; 143: 408–413
- Nicholas J. M., Lipshitz J., Schreiber E. Phencyclidine: Its transfer across the placenta as well as into breast milk. Am. J. Obstet. Gynecol. 1982; 143: 143–146
- Rawson R. A., Tennant F., McCann M. A. Characteristics of 68 chronic phencyclidine abusers who sought treatment. Drug Alcohol Depend. 1981; 8: 223–227